Mohanty, I., Fazelinia, H., Raimo, S., Ding, H., Spruce, L., Symeonidou, M., Tenopoulou, M., Ichinose, F., Yamashita, H., Shimokawa, H., Masato, T., Doulias, P.-T., & Ischiropoulos, H. (2025). Proteomic surveys of the mouse heart unveil cardiovascular responses to nitric oxide/cGMP signaling deficiencies. Communications Biology, 8(1). https://doi.org/10.1038/s42003-025-08203-8

Rubinelli, L., Manzo, O. L., Sungho, J., Del Gaudio, I., Bareja, R., Marino, A., Palikhe, S., Di Mauro, V., Bucci, M., Falcone, D. J., Elemento, O., Ersoy, B., Diano, S., Sasset, L., & Di Lorenzo, A. (2025). Suppression of endothelial ceramide de novo biosynthesis by Nogo-B contributes to cardiometabolic diseases. Nature Communications, 16(1). https://doi.org/10.1038/s41467-025-56869-9

Charisis, S., Ntanasi, E., Mamalaki, E., Skaperda, Z., de la Colina, A. N., Kouretas, D., & Scarmeas, N. (2024). Association of Blood Redox Markers with Alzheimer Disease Biomarkers and Cognitive Performance. Alzheimer’s & Dementia, 20(S2). Portico. https://doi.org/10.1002/alz.085708

Zeni, C., Dedic, N., Jones, P., Wu, S., Anacker, C., Hajos-Korcsok, E., Synan, C., Milanovic, S., Hopkins, S., Bristow, L., & Koblan, K. (2022). Ulotaront improves metabolic parameters in rodent models of weight gain and hyperglycemia. Neuroscience Applied, 1, 100356. https://doi.org/10.1016/j.nsa.2022.100356

Gautheron, J., Morisseau, C., Chung, W. K., Zammouri, J., Auclair, M., Baujat, G., Capel, E., Moulin, C., Wang, Y., Yang, J., Hammock, B. D., Cerame, B., Phan, F., Fève, B., Vigouroux, C., Andreelli, F., & Jeru, I. (2021). EPHX1 mutations cause a lipoatrophic diabetes syndrome due to impaired epoxide hydrolysis and increased cellular senescence. ELife, 10. CLOCKSS. https://doi.org/10.7554/elife.68445